Pacira BioSciences
PCRX
PCRX
259 hedge funds and large institutions have $2.75B invested in Pacira BioSciences in 2021 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 95 increasing their positions, 90 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
1.62% less ownership
Funds ownership: 112.14% → 110.52% (-1.6%)
8% less capital invested
Capital invested by funds: $2.99B → $2.75B (-$242M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
259
Holding in Top 10
3
Calls
$6.09M
Puts
$2.09M
Top Buyers
| 1 | +$52.4M | |
| 2 | +$11.5M | |
| 3 | +$5.36M | |
| 4 |
SCM
Spyglass Capital Management
San Francisco,
California
|
+$5.24M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$4.78M |
Top Sellers
| 1 | -$21.6M | |
| 2 | -$14.4M | |
| 3 | -$13.7M | |
| 4 |
DM
Deerfield Management
New York
|
-$10.1M |
| 5 |
Morgan Stanley
New York
|
-$9.62M |